Savara Inc. (SVRA)
 NASDAQ: SVRA · Real-Time Price · USD
 4.300
 -0.040 (-0.92%)
  Oct 30, 2025, 4:00 PM EDT - Market closed
Savara Employees
Savara had 59 employees as of December 31, 2024. The number of employees increased by 22 or 59.46% compared to the previous year.
Employees 
 59
Change (1Y) 
 22
Growth (1Y) 
 59.46%
Revenue / Employee 
 n/a
Profits / Employee 
 -$1,870,034
Market Cap 
905.97M
Employees Chart
Employees History
| Date | Employees | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 59 | 22 | 59.46% | 
| Dec 31, 2023 | 37 | 9 | 32.14% | 
| Dec 31, 2022 | 28 | 6 | 27.27% | 
| Dec 31, 2021 | 22 | -5 | -18.52% | 
| Dec 31, 2020 | 27 | -13 | -32.50% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Related Stocks
| Company Name | Employees | 
|---|---|
| UnitedHealth Group | 400,000 | 
| Johnson & Johnson | 138,100 | 
| Thermo Fisher Scientific | 125,000 | 
| Abbott Laboratories | 114,000 | 
| AstraZeneca | 92,900 | 
| Novo Nordisk | 77,349 | 
| Novartis AG | 75,883 | 
| Merck & Co. | 75,000 | 
SVRA News
- 18 hours ago - SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - GlobeNewsWire
- 1 day ago - Savara Announces Pricing of $130.0 Million Public Offering of Common Stock and Pre-funded Warrants - Business Wire
- 1 day ago - Savara Announces Proposed Public Offering - Business Wire
- 1 day ago - Savara announces $75M Royalty Funding Agreement with RTW to Support the Potential Launch of MOLBREEVI* in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) - Business Wire
- 2 days ago - SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - PRNewsWire
- 7 days ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - PRNewsWire
- 13 days ago - Savara Announces Chief Medical Officer (CMO) Transition - Business Wire
- 16 days ago - SAVARA DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Reminds Savara Investors to Contact the Firm Before the November 7th Deadline - GlobeNewsWire